1-3 of 3
Stephen Janofsky
Close
Sort by
Journal Articles

Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma

Clinical Trials & Observations
Aaron P. Rapoport, Nicole A. Aqui, Edward A. Stadtmauer, Dan T. Vogl, Hong-Bin Fang, Ling Cai, Stephen Janofsky, Anne Chew, Jan Storek, Gorgun Akpek, Ashraf Badros, Saul Yanovich, Ming T. Tan, Elizabeth Veloso, Marcela F. Pasetti, Alan Cross, Sunita Philip, Heather Murphy, Rita Bhagat, Zhaohui Zheng, Todd Milliron, Julio Cotte, Andrea Cannon, Bruce L. Levine, Robert H. Vonderheide, Carl H. June
Journal: Blood
Blood (2011) 117 (3): 788–797.
https://doi.org/10.1182/blood-2010-08-299396
Published: 2011
Includes: Supplemental data
Journal Articles

Phase II Trial of Lenalidomide - Dexamethasone - Rituximab in Relapsed or Refractory Indolent B-Cell or Mantle Cell Lymphomas Resistant to Rituximab.

Tahamtan Ahmadi, MD, PhD, Elise A. Chong, BA, Amanda Gordon, BA, BSN, RN, Nicole A. Aqui, MD, Lisa H. Downs, CRNP, Leah Leinbach, Steven C. Goldstein, MD, Sunita D. Nasta, MD, Stephen Janofsky, Tapan N. Maniar, MD, Jakub Svoboda, MD, Stephen J. Schuster, MD
Journal: Blood
Blood (2009) 114 (22): 1700.
https://doi.org/10.1182/blood.V114.22.1700.1700
Published: 2009
Journal Articles

Schedule Dependent Effects of Adoptively Transferred Autologous T Cells After AutoSCT for Myeloma: Accelerated Immune Recovery Is Associated with Improved Event-Free Survival.

Aaron P. Rapoport, MD, Nicole A. Aqui, MD, Edward A. Stadtmauer, MD, Dan T. Vogl, MD, Hong-Bin Fang, PhD, Stephen Janofsky, BS, Jan Storek, MD, PhD, Anne Chew, PhD, Elizabeth Veloso, JD, Gorgun Akpek, MD, MS, Saul Yanovich, MD, Ming T. Tan, PhD, Yin Wu, MD, Alan Cross, MD, Sunita Philip, MPH, Heather Murphy, Rita Bhagat, RN, Yiping Liu, Bruce Levine, PhD, Robert H. Vonderheide, MD, DPhil, Carl H. June, MD
Journal: Blood
Blood (2009) 114 (22): 784.
https://doi.org/10.1182/blood.V114.22.784.784
Published: 2009